Logo image of CDNA

CAREDX INC (CDNA) Stock Analyst Earnings Estimates

NASDAQ:CDNA - Nasdaq - US14167L1035 - Common Stock - Currency: USD

22.29  -1.09 (-4.66%)

After market: 22.18 -0.11 (-0.49%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
CDNA revenue by date.CDNA revenue by date.
296.4M
54.21%
321.8M
8.57%
280.324M
-12.89%
337.96M
20.56%
376.9M
11.52%
432.52M
14.76%
510.26M
17.97%
EBITDA
YoY % growth
CDNA ebitda by date.CDNA ebitda by date.
-20.9M
-34.93%
-65.6M
-213.88%
-89.657M
-36.67%
24.052M
126.83%
32.97M
37.08%
62.928M
90.86%
102.97M
63.63%
EBIT
YoY % growth
CDNA ebit by date.CDNA ebit by date.
-29.7M
-32.00%
-77.2M
-159.93%
-104.043M
-34.77%
14.073M
113.53%
23.179M
64.71%
52.285M
125.57%
27.312M
-47.76%
Operating Margin
CDNA operating margin by date.CDNA operating margin by date.
-10.02%-23.99%-37.12%4.16%6.15%12.09%5.35%
EPS
YoY % growth
CDNA eps by date.CDNA eps by date.
0.29
31.82%
-0.39
-234.48%
-0.64
-64.10%
0.51
179.69%
0.59
16.29%
0.89
50.78%
1.83
104.18%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.13
177.14%
0.09
386.59%
0.13
-46.96%
0.17
24.90%
0.20
54.26%
0.22
161.00%
0.27
100.00%
0.29
63.33%
0.30
46.22%
Revenue
Q2Q % growth
85.797M
30.85%
87.41M
21.32%
93.002M
0.79%
96.436M
16.35%
99.264M
15.70%
99.792M
14.17%
105.7M
13.65%
109.48M
13.53%
113.87M
14.71%
EBITDA
Q2Q % growth
4.416M
142.16%
4.781M
131.63%
7.287M
118.57%
9.726M
2,752.20%
10.959M
148.17%
11.67M
144.09%
14.954M
105.21%
18.311M
88.27%
20.447M
86.58%
EBIT
Q2Q % growth
4.471M
117.98%
1.969M
110.40%
4.696M
216.53%
7.475M
171.24%
9.039M
102.17%
13.013M
560.89%
16.011M
240.95%
17.115M
128.96%
17.817M
97.11%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
0.14
177.78%
0.010.131,272.55%
Q2 2024
Q2Q % growth
0.25
238.89%
-0.150.40270.21%
Q1 2024
Q2Q % growth
-0.03
72.73%
-0.210.1885.72%
Q4 2023
Q2Q % growth
-0.17
-142.86%
-0.270.1037.44%
Q3 2023
Q2Q % growth
-0.18
-200.00%
-0.400.2255.37%
Q2 2023
Q2Q % growth
-0.18
-38.46%
-0.320.1443.07%
Q1 2023
Q2Q % growth
-0.11
15.38%
-0.110.000.15%
Q4 2022
Q2Q % growth
-0.07
-133.33%
-0.090.0220.39%
Q3 2022
Q2Q % growth
-0.06
-185.71%
-0.140.0857.98%
Q2 2022
Q2Q % growth
-0.13
-218.18%
-0.11-0.02-13.80%
Q1 2022
Q2Q % growth
-0.13
-192.86%
-0.05-0.08-154.90%
Q4 2021
Q2Q % growth
-0.03
-137.50%
0.03-0.06-190.50%
Q3 2021
Q2Q % growth
0.07
-30.00%
0.010.06471.90%
Q2 2021
Q2Q % growth
0.11
175.00%
0.050.06107.39%
Q1 2021
Q2Q % growth
0.14 0.010.132,645.10%
Q4 2020
Q2Q % growth
0.08
100.00%
0.020.06264.80%
Q3 2020
Q2Q % growth
0.10
400.00%
-0.040.14330.68%
Q2 2020
Q2Q % growth
0.04 -0.040.08198.04%
Q1 2020
Q2Q % growth
0.00
-100.00%
0.03-0.03-100.00%
Q4 2019
Q2Q % growth
0.04 0.020.02161.44%
Q3 2019
Q2Q % growth
0.02 0.010.0196.08%
Q2 2019
Q2Q % growth
0.00 0.000.00-100.00%
Q1 2019
Q2Q % growth
0.05 -0.030.08250.83%
CDNA Yearly EPS VS EstimatesCDNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 1.5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
82.883M
23.35%
82.136M747K0.91%
Q2 2024
Q2Q % growth
92.274M
31.26%
69.218M23.056M33.31%
Q1 2024
Q2Q % growth
72.049M
-6.75%
64.403M7.646M11.87%
Q4 2023
Q2Q % growth
65.569M
-20.41%
64.928M641K0.99%
Q3 2023
Q2Q % growth
67.192M
-15.33%
54.201M12.991M23.97%
Q2 2023
Q2Q % growth
70.301M
-12.81%
63M7.301M11.59%
Q1 2023
Q2Q % growth
77.262M
-2.72%
82.313M-5.051M-6.14%
Q4 2022
Q2Q % growth
82.38M
3.99%
83.293M-913K-1.10%
Q3 2022
Q2Q % growth
79.36M
4.99%
84.274M-4.914M-5.83%
Q2 2022
Q2Q % growth
80.63M
8.68%
83.484M-2.854M-3.42%
Q1 2022
Q2Q % growth
79.42M
17.83%
80.496M-1.076M-1.34%
Q4 2021
Q2Q % growth
79.22M
35.10%
79.657M-437K-0.55%
Q3 2021
Q2Q % growth
75.59M
41.63%
75.528M62K0.08%
Q2 2021
Q2Q % growth
74.19M
77.49%
69.117M5.073M7.34%
Q1 2021
Q2Q % growth
67.4M
75.61%
62.275M5.125M8.23%
Q4 2020
Q2Q % growth
58.64M
63.71%
56.623M2.017M3.56%
Q3 2020
Q2Q % growth
53.37M
57.85%
54.069M-699K-1.29%
Q2 2020
Q2Q % growth
41.8M
32.91%
36.323M5.477M15.08%
Q1 2020
Q2Q % growth
38.38M
47.73%
38.775M-395K-1.02%
Q4 2019
Q2Q % growth
35.82M 36.497M-677K-1.85%
Q3 2019
Q2Q % growth
33.81M 33.807M3K0.01%
Q2 2019
Q2Q % growth
31.45M 28.606M2.844M9.94%
Q1 2019
Q2Q % growth
25.98M 24.786M1.194M4.82%
CDNA Yearly Revenue VS EstimatesCDNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS148.83% 148.83% 18.11% 34.1%
Revenue2.38% 2.38% 0.24% 0.8%